Prostate Cancer

  • Most Topular Stories

  • Ancient Remedy Slows Prostate Tumor Cell Proliferation

    Prostate / Prostate Cancer News From Medical News Today
    8 May 2012 | 2:00 am
    An over-the-counter natural remedy derived from honeybee hives arrests the growth of prostate cancer cells and tumors in mice, according to a new paper from researchers at the University of Chicago Medicine. Caffeic acid phenethyl ester, or CAPE, is a compound isolated from honeybee hive propolis, the resin used by bees to patch up holes in hives...
  • High PSA Causes

    About.com: Prostate Cancer
    16 May 2012 | 7:09 am
    What are some other causes of an elevated PSA? Thousands of men each year are told that they have a high PSA level after undergoing a routine screening test. The most important and most concerning cause of an elevated PSA is prostate cancer. However, prostate cancer is only one of many potential causes of an elevated PSA.
  • What Is The Actual Survival Advantage for Men Who Take Provenge? It’s Longer Than We Thought!

    Malecare's Advanced Prostate Cancer
    Joel
    3 May 2012 | 7:55 pm
    Understanding and deciding on appropriate treatments for men with advanced prostate cancer can be confusing. All the treatments come with side effects and one never knows what the benefits might be for an individual. Even with good clinical trials, men with advanced prostate cancer still need to navigate a most unclear path. Provenge, ever since is introduction has attracted nothing but controversy. The first rumblings go all the way back to its initial FDA hearing and just continues all the way to today. I cannot think of many drugs or treatments that can boast of such a rocky history. When…
  • Download the Updated Advanced Prostate Cancer Book

    Malecare's Advanced Prostate Cancer
    Joel
    10 May 2012 | 4:43 pm
    Malecare’s Advanced Prostate Cancer Book has just had a major update from its first edition. This updated edition can be downloaded for free from the Malecare web page at www.malecare.org. When you get to the page click the box in the upper left of the page that says “ADVANCED PROSTATE CANCER.” Then go to the section that says Advanced Prostate Cancer and fill in your name and email address so we can contact you when there are additional updates. The Advanced Prostate Cancer Book is written for both the newly diagnosed who do not have any understanding of the disease to the…
  • Vitamin E in diet protects against many cancers, study suggests

    ScienceDaily: Prostate Cancer News
    23 Apr 2012 | 12:20 pm
    Scientists believe that two forms of vitamin E – gamma and delta-tocopherols – found in soybean, canola and corn oils as well as nuts do prevent colon, lung, breast and prostate cancers while the alpha tocopherols found in vitamin E supplements provide no such protection.
  • add this feed to my.Alltop

    MedWorm: Prostate Cancer

  • A search for reliable molecular markers of prognosis in prostate cancer: a study of 240 cases.

    16 May 2012 | 5:07 am
    Authors: Tradonsky A, Rubin T, Beck R, Ring B, Seitz R, Mair S Abstract Most prostate cancers are treated, although more than 80% remain clinically insignificant and fewer than 3% are fatal. This retrospective study of 240 radical prostatectomy cases with comprehensive follow-up was a search for reliable markers of prostate cancer prognosis evaluable on biopsy specimens to enable minimization of unnecessary treatment, morbidity, and costs. Representative cancer and benign tissue from each prostatectomy specimen was made into tissue microarrays and stained with antibodies targeting 20 gene…
  • The dynamics of death in prostate cancer.

    16 May 2012 | 5:07 am
    In this study, hazard functions were derived for prostate cancer by using survival data on large numbers of patients with prostate cancer with data in the Surveillance, Epidemiology and End Results (SEER) database. The results demonstrate a form of prostate cancer that rapidly evolves to cause death within 5 years, and this form of tumor is only partly identified by routine prognostic variables such as serum prostate-specific antigen (PSA) level, histologic grade, and quantity of tumor. The results also validate the presence of a reservoir of nonfatal prostate cancers that have increased…
  • Prostate cancer drug Abiraterone set for approval in England and Wales but not Scotland

    16 May 2012 | 3:02 am
    Abiraterone, marketed as Zytiga, should be given to patients in England and Wales, after a U-turn by the NHS rationing body. It has already been turned down in Scotland. (Source: the Mail online | Health)
  • NHS ban on pill to treat prostate cancer is lifted

    15 May 2012 | 9:01 pm
    MEN in the advanced stages of prostate cancer were given hope yesterday when the health -watchdog made a U-turn to approve a drug that can give them precious months of life. (Source: Daily Express - Health)
  • Gold Nanocage-CNT Hybrid for Targeted Imaging and Photothermal Destruction of Cancer

    15 May 2012 | 7:10 pm
    Chem. Commun., 2012, Accepted ManuscriptDOI: 10.1039/C2CC32313C, CommunicationParesh Ray, Sadia Khan, Zhen Fan, Rajashekar Kanchanapally, Dulal Senapati, Anant Singh, Lule BeqaThis communication reports the design of novel aptamer conjugated gold nanocage decorated SWCNTs hybrid nanomaterial for targeted imaging and selective photothermal destruction of prostate cancer cell.The content of this RSS Feed (c) The Royal Society of Chemistry (Source: RSC - Chem. Commun. latest articles)
 
 
 
  • add this feed to my.Alltop

    Prostate Cancer - Articles - Zimbio

  • Prostate Cancer w/ Bone Metastasis

    16 May 2012 | 5:09 am
    Gerald Aptaker, 71. Stage IV Prostate Cancer with multiple bone metastases in bilateral ribs, thoracic spine, sacrum, pelvis and left femur responded dramatically to the Issels Treatment. Within 3 weeks the PSA of 3524 dropped to 639.9, pain minimized, appetite and overall well being improved and energy level went up. Laboratory studies of July 1st, about 1 month after Geralds discharge from the Issels Treatment Center, showed a PSA level of 17.27 and Gerald reported a substantial improvement in his quality of life, with practically no bone pain, no limitations in his range of motion. August…
  • Prostate Cancer Awareness Polo Health Golf Shirt by CafePress

    16 May 2012 | 4:50 am
    Prostate Cancer Awareness Polo Health Golf Shirt by CafePress Show your support for Prostate Cancer Awareness Health Tee, TShirt, Shirt. About our Golf Shirt: Tee off in casual style. Our pique knit golf t-shirt is a comfortable, lightweight way to play 18-holes and beat the heat. Features, stylish white pearl buttons, yet it feels like wearing your favorite t-shirt. Dress it up or down. Throw a blazer over lat. List Price: $ 20.00 Price: $ 20.00 More Prostate Cancer Apparel Products
  • Prostate Cancer Awareness Ribbon Coffee Mug

    15 May 2012 | 4:53 pm
    Prostate Cancer Awareness Ribbon Coffee Mug 11 Ounce Ceramic Coffee Mug Dishwasher and Microwave Safe Flag will not fade or discolor Makes a Great Gift or Present High Quality with Lasting Durability – Made in the USA The Prostate Cancer Ribbon proudly displayed on an 11 ounce coffee mug. There is no better way to achieve awareness or remembrance for the meaning of the Prostate Cancer Ribbon than to display it on your coffee mug for everyone to see. The coffee mug is 11 ounces, it is dishwasher safe as well as microwave safe. The colors will not fade or run. Start gaining awareness…
  • Men’s Health Prostate cancer Organic Men’s Fitted T-Shirt by CafePress

    13 May 2012 | 4:56 pm
    Men’s Health Prostate cancer Organic Men’s Fitted T-Shirt by CafePress Lightweight for summer comfort or winter layering, our Men’s Organic T-shirt is one of our most popular fine tees. It’s what to wear when you care about having 100% organically-grown cotton next to your skin. The next best thing to nothing, naturally. List Price: $ 32.50 Price: $ 32.50 Related Prostate Cancer Shirt Products
  • Prostate Cancer (Understanding Disease: Infectious Diseases & Oncology)

    13 May 2012 | 7:09 am
    Get the facts on Prostate Cancer with this 100%-accurate animated video. Part of Focus Apps’ Understanding Disease: Infectious Diseases & Oncology series, the Prostate Cancer app explores the anatomy of the prostate gland. Prostate cancer is most often referred to as adenocarcinoma or glandular carcinoma. It arises in the peripheral zone from the semen-secreting cells of the prostate gland, a part of the male reproductive system. Understand symptoms, causes, risk factors, staging and prognosis, diagnostic methods, evaluation, treatment options, and recent advances related to…
 
  • add this feed to my.Alltop

    THE "NEW" PROSTATE CANCER INFOLINK

  • Abiraterone in the UK: rumors are rife …

    Sitemaster
    15 May 2012 | 10:29 am
    According to recent articles in the media, the National Institute for Clinical Excellence (NICE) will shortly issue a recommendation that abiraterone is covered for routine use in the UK among men with chemotherapy-refractory, metastatic, castration-resistant prostate cancer (mCRPC). If one believes the media reports (see The Daily Mail yesterday and The Daily Telegraph today), one [...]
  • Wanna learn about being a consumer/patient reviewer for the DoD PCRP?

    Sitemaster
    14 May 2012 | 6:28 pm
    On Wednesday this week, you can join an hour-long webcast at which Dr. Carolyn Best and a colleague from the Department of Defense Prostate Cancer Research Program (DoD PCRP) will explain what is involved and how to apply. Sign yourself up right NOW! The DoD PCRP is the single largest government-funded research program that is [...]
  • DNA methylation and the aggressiveness of prostate cancer

    Sitemaster
    14 May 2012 | 6:08 pm
    According to a media release from the Mayo Clinic earlier today, “Alterations to the ‘on-off’ switches of genes occur early in the development of prostate cancer and could be used as biomarkers to detect the disease months or even years earlier than current approaches.” The relevant research paper has — supposedly –  just been published [...]
  • PBRT vs. IMRT — are we about to get the definitive trial?

    Sitemaster
    14 May 2012 | 8:04 am
    According to an article in the Boston Globe this morning, we are (supposedly and finally) going to get the study needed to try to demonstrate whether there is a real clinical benefit to proton beam radiation therapy as compared to modern, intensity-modulated radiation therapy in men with localized prostate cancer! The study is to be [...]
  • Expert video-discussion on evolution in the management of late stage prostate cancer

    Sitemaster
    12 May 2012 | 6:11 am
    Here is a link to a recent 20-minute video-discussion on the Medscape web site between an number of European experts on evolutions in the management of castration-resistant (and earlier forms of) prostate cancer. (You do need to sign up to be able to see material on the Medscape web site, but you can opt out [...]
  • add this feed to my.Alltop

    About.com Prostate Cancer: What's Hot Now

  • Stage 3 Prostate Cancer

    prostatecancer.guide@about.com
    16 May 2012 | 6:10 am
    How advanced is stage 3 prostate cancer? How much has prostate cancer spread if it is stage 3?
  • Alkaline Phosphatase

    prostatecancer.guide@about.com
    16 May 2012 | 6:10 am
    Alkaline phosphatase is an enzyme found in the blood that can signal that prostate cancer has spread to the bones. The test for alkaline phosphatase is a common and important aspect of the monitoring of prostate cancer.
  • Prostate Cancer Chemotherapy

    prostatecancer.guide@about.com
    16 May 2012 | 6:10 am
    Chemotherapy is not commonly used to treat prostate cancer. However, there are two specific sets of circumstances where chemotherapy is typically used. It is important to know the basics about this important form of treatment.
  • What Is Prostate Cancer?

    prostatecancer.guide@about.com
    16 May 2012 | 6:10 am
    What is prostate cancer: The three key questions that anyone interested in this disease must have answered. What is the prostate? What is cancer? What is prostate cancer?
  • PET Scan for Prostate Cancer

    prostatecancer.guide@about.com
    16 May 2012 | 6:10 am
    The PET scan for prostate cancer is an often misunderstood test which is sometimes used to determine the extent of spread of prostate cancer. Learn all about the PET scan for prostate cancer and why prostate cancer is different from any other type of cancer when it comes to PET.
  • add this feed to my.Alltop

    About.com: Prostate Cancer

  • Robot-Assisted Surgery

    16 May 2012 | 7:09 am
    Robot-assisted prostate surgery is a relatively new option for treating prostate cancer. This surgery is of great interest to men with prostate cancer as well as the general public, but there are plenty of misconceptions about it. Learn what this procedure really entails here.
  • Important Questions About Radiation Therapy

    16 May 2012 | 7:09 am
    Radiation therapy is a widely used treatment for prostate cancer. Radiation therapy can be administered from outside the body (external beam radiation therapy) or from inside the body (brachytherapy). What are the important questions about radiation therapy?
  • High PSA Causes

    16 May 2012 | 7:09 am
    What are some other causes of an elevated PSA? Thousands of men each year are told that they have a high PSA level after undergoing a routine screening test. The most important and most concerning cause of an elevated PSA is prostate cancer. However, prostate cancer is only one of many potential causes of an elevated PSA.
  • Uncommon Symptoms List

    16 May 2012 | 7:09 am
    Urinary problems are the most common initial symptoms of prostate cancer, however, there a number of uncommon symptoms that you should be aware of as well.
  • Prostate Infection

    16 May 2012 | 7:09 am
    Prostate infections can cause a number of severe symptoms, can lead to dangerous complications, and can mimic the symptoms of more serious conditions such as prostate cancer. Learn all about prostate infections here.
 
  • add this feed to my.Alltop

    Malecare's Advanced Prostate Cancer

  • Download the Updated Advanced Prostate Cancer Book

    Joel
    10 May 2012 | 4:43 pm
    Malecare’s Advanced Prostate Cancer Book has just had a major update from its first edition. This updated edition can be downloaded for free from the Malecare web page at www.malecare.org. When you get to the page click the box in the upper left of the page that says “ADVANCED PROSTATE CANCER.” Then go to the section that says Advanced Prostate Cancer and fill in your name and email address so we can contact you when there are additional updates. The Advanced Prostate Cancer Book is written for both the newly diagnosed who do not have any understanding of the disease to the…
  • GTx Receives clearance for New Capesaris Trials

    Joel
    8 May 2012 | 8:17 pm
    GTx Inc. announced that FDA regulators will allow it to restart the clinical trials of its investigational prostate cancer drug Capesaris for men with castrate resistant advanced prostate cancer. They anticipate that the trials of Capesaris will begin during the third quarter of 2012. The trial is designed to evaluate Capesaris as a secondary treatment for advanced prostate cancer that no longer responds to hormone treatment, a condition known as being castrate resistant. The trial protocol will test three different doses of Capesaris on 75 men. In February the he FDA ordered GTx to stop the…
  • Why Are Gays Excluded From Medical Research Studies?

    Joel
    5 May 2012 | 8:53 pm
    For a reason that I can not figure out there are a small but still significant portion of medical studies that automatically exclude gays from participating without an apparent scientific reason. These studies usually have requirements that the subject be in a “reciprocal relationship with a person of the opposite sex.” Sometimes the exclusion of gays is appropriate, for example if the study were looking at how HIV spreads during male-female sex. In this example the researchers would only want heterosexual subjects. But in most studies that exclude gays from the subject pool there is…
  • What Is The Actual Survival Advantage for Men Who Take Provenge? It’s Longer Than We Thought!

    Joel
    3 May 2012 | 7:55 pm
    Understanding and deciding on appropriate treatments for men with advanced prostate cancer can be confusing. All the treatments come with side effects and one never knows what the benefits might be for an individual. Even with good clinical trials, men with advanced prostate cancer still need to navigate a most unclear path. Provenge, ever since is introduction has attracted nothing but controversy. The first rumblings go all the way back to its initial FDA hearing and just continues all the way to today. I cannot think of many drugs or treatments that can boast of such a rocky history. When…
  • Zytiga in High Doses and Zytiga Combined with MDV3100 Increase the Length of Response Time In Men with Advanced Prostate Cancer

    Joel
    1 May 2012 | 6:22 pm
    According to recent trials led by The Institute of Cancer Research (ICR) (UK) and The Royal Marsden (UK) combining Zytiga (abiraterone acetate) with the yet FDA unapproved investigational drug MDV3100 could increase the number of men, with advanced prostate cancer, who respond to treatment as well as the length of time they benefit. A new study published today in Cancer Research has identified a reason why men with metastatic prostate cancer ultimately develop resistance to Zytiga. In a laboratory study, Dr Gerhardt Attard and colleagues found that the steroids that are given in combination…
  • add this feed to my.Alltop

    Prostate Cancer Advocacy and Action

  • why don’t we care?

    Mary
    10 May 2012 | 7:12 pm
    Just reflecting on an incident last year. I was out for a jog in my neighborhood, I saw a young family out for a walk… always a wonderful thing to see. The young daughter got something in her eye and began to cry. Both parents immediately rushed to her, letting go of the baby stroller the mother was pushing. As they huddled around their daughter – the baby stroller slowly gained momentum down a hill towards an intersection. My own instinct caused me to pick up pace to a panicked run as I crossed the street to keep the carriage from rolling into the road… with no idea of its…
  • Ignorance trumps many dimensions of social justice

    Mary
    9 May 2012 | 7:12 pm
    What happened yesterday in NC (passing of NC Amendment 1) is shameful beyond reason. If you claim to be an advocate for men’s health and you do not advocate for veterans or if you support anti LGBT legislation you are NOT an advocate for men’s health – period.
  • Mayan Prophecy

    Mary
    4 May 2012 | 4:47 pm
    I’ve been thinking lately about the Mayan Prophecy (the world ending on 12/21/12). Apparently a lot of people believe that this end of days might actually be a global re-alignment in thought… whereas we have a whole world that is dominated by patriarchal masculine attitudes and behaviors, even in women, there might be a re-introduction of the feminine divine… where our collective thoughts are more balanced towards nurturing, compassion, and respect vs. well… domineering self-interested BS and the unhealthy variety of competitive attitudes that are born and fostered…
  • Ryan O’Neal and Warren Buffet

    Mary
    18 Apr 2012 | 6:18 pm
    Two well-known celebrities were diagnosed with cancer this week – and each case illustrates the confusion that is indicative of the experience of cancer diagnosis in our broken medical system. Ryan O’neal announced his diagnosis last Friday (4/13) stating that he has stage 4 prostate cancer, but has been given a “positive” prognosis because it was caught early. Stage 4 PCa is never a positive prognosis, and in all likelihood it was not caught early… if it was caught early that is one seriously aggressive cancer that is very likely well beyond hope for “cure.”…
  • Fred Gersh Died Today

    Darryl
    5 Apr 2012 | 2:09 pm
    Fred Gersh died earlier this morning, from the Prostate Cancer that he had been fighting for many years. Fred was a friend and ally to Malecare. He spent much of the last decade of his life as a prostate cancer advocate. I met Fred during one of the many conferences we both attended. One day, several years ago, he took my arm and asked me, “what is it about gay men…why does Malecare exit?” That was the start of many conversations about LGBT life, history, sex and love and prostate cancer. Fred was a genuine learner, and, during the last year or so, I witnessed him as a teacher,…
  • add this feed to my.Alltop

    prostate-report.org

  • Prostate drug abiraterone ’set for NHS use’

    Admin
    16 May 2012 | 1:33 pm
    A drug for advanced prostate cancer is likely to be approved for NHS use in England and Wales after the medical watchdog reversed an earlier decision. Abiraterone, initially rejected by NICE for not being cost effective, costs about £3,000 a month and can extend life by more than three months. The decision prompted an angry response from patients and cancer charities. Final approval will be made in June after the manufacturer offered the oral tablet at an undisclosed lower price.
  • New tests to detect prostate cancer early

    Admin
    15 May 2012 | 3:10 pm
    Prostate-specific antigen (PSA) testing is one way to find prostate tumors early, but PSA testing can miss some cancers or produce a false-positive result. Meanwhile, researchers at the University of Michigan believe a new urine test is more accurate. The urine test works by identifying gene fusions that occur when pieces of two chromosomes stick together. These fusions are common in prostate cancer. The urine test identified 80 percent of patients with it.
  • Biomarkers for prostate cancer detection discovered

    Admin
    14 May 2012 | 1:06 pm
    A new Mayo Clinic study has found alterations to the “on-off” switches of genes occur early in the development of prostate cancer and could be used as biomarkers - known as DNA methylation profiles - to detect the disease months or even years earlier than current approaches. These biomarkers also can predict if the cancer is going to recur and if that recurrence will remain localized to the prostate or, instead, spread to other organs. The team leades says the PSA test detects any prostate abnormality, whether inflammation, cancer, infection or enlargement, while the DNA…
  • National Institute for Clinical Excellence rejects “routine” use of cabazitaxel in UK

    Admin
    13 May 2012 | 2:41 pm
    A media release issued today by the National Institute for Clinical Excellence (NICE) in the UK, says the institute’s advisory board will not recommend “routine” use of cabazitaxel for the treatment of metastasic, castration-resistant prostate cancer. It is clear from the media release that NICE decided that the price for treatment with cabazitaxel (also known as Jevtana) did not, in its opinion, justify the potential benefits when the risk of complications and side effects of treatment were taken into account. However, NICE will recommend use of the drug in ongoing or future clinical…
  • Updated version of book on advanced prostate cancer

    Admin
    12 May 2012 | 5:51 am
    Malecare has just issued an updated version of its free book on recurrent and advanced prostate cancer. Many people have gained great benefit from the first edition of this book, and we are sure that the new version is equally useful. However, you do have to “sign up” to be able to download the new edition, which will clearly mean that readers start to receive a regular stream of e-mails about related Malecare services. If interested you may sign up here
 
  • add this feed to my.Alltop

    Prostate Cancer Blog for Wives and Partners

  • XGEVA® (denosumab) Does Not Receive FDA Approval

    3 May 2012 | 8:22 pm
    The FDA has not approved the use of denosumab to treat men with castration-resistant prostate cancer at high risk of developing bone metastases, according to an Amgen press release. The FDA determined that the effect on bone metastases-free survival was of insufficient magnitude to outweigh the risks (including osteonecrosis of the jaw) of denosumab in the intended population, and requested data from adequate and well-controlled trials demonstrating a favorable risk-benefit profile for denosumab. May 3, 2012.
  • Small High Intensity Focused Ultrasound Study Shows Promise

    17 Apr 2012 | 5:18 pm
    Although high intensity focused ultrasound (HIFU) is not approved for use in the United States, a small UK study by Ahmed et al, is reporting favorable results in the early online version of The Lancet Oncology. With HIFU, small lumps of cancerous prostate tissue are removed, making it somewhat similar to lumpectomy for breast cancer. Then soundwaves cause targeted tissue to heat up, which kills the cancer cells. Proponents claim that HIFU is extremely accurate, effective, and has fewer side effects than conventional treatments, such as radical prostatectomy. In this study of 42 men, 12…
  • Study: Antifungal Treatment for Prostate Cancer

    12 Apr 2012 | 12:17 pm
    Antifungal treatment is sometimes used in men with castration-resistant prostate cancer (CRPC). In a recent study by Antonarakis et al, 46 men with CRPC either received daily 200 mg or 600 mg of the antifungal drug itraconazole (Sporanox is the brand name). Results of the study have not yet been published, but were presented at the American Association for Cancer Research annual meeting. MedPage Today reported that men in the high-dose itraconazole group had a progression-free survival (PFS) of 48.4% at 24 weeks versus 11.8% for the men in the 200-mg group. The median PFS was 17 weeks for the…
  • Study: Brachytherapy and Men with Gleason 7 Prostate Cancer

    29 Mar 2012 | 11:00 am
    Researchers in British Columbia who compared the records of 1,500 men with prostate cancer (439 men had Gleason 7 disease; 362 men had Gleason 3+4 and 77 men had 4+3 disease) have determined that treatment with I-125 brachytherapy seeds with 6 months of hormone treatment demonstrated excellent biochemical no evidence of disease (using the Phoenix definition of biochemical recurrence, which is nadir PSA + 2.0 ng/mL following brachytherapy) in men with Gleason 7 disease after 5 years. They also found no difference in results between men with Gleason 3+4 or 4+3 disease. These men received I-125…
  • Prostate Cancer Statistics for 2012

    20 Mar 2012 | 2:29 pm
    Before you read these prostate cancer statistics, remember that every man is different and every case of prostate cancer is different.
  • add this feed to my.Alltop

    Healthy Living News from Prostate.net

  • Ashwagandha Herb Can Reverse Memory Loss

    James Craig
    30 Apr 2012 | 7:26 pm
    Although the work is preliminary, researchers at the National Brain Research Centre (NBRC) say they have shown that the herb ashwagandha may reverse memory loss in Alzheimer’s disease. Their findings were made in mice modified to have Alzheimer’s, a commonly used way to study the disease. Alzheimer’s disease is a progressive brain disease and the most common type of dementia. One characteristic of the disease is the accumulation of protein deposits (beta amyloid) as plaque in the brain, and much of the prevention and treatment research has focused on ways to eliminate this plaque. NBRC…
  • Prostate Cancer Risk Higher in Men with Breast Cancer Gene

    Editor
    23 Apr 2012 | 7:01 pm
    Results of a new study support what researchers have known for some time: there is a connection between breast cancer and prostate cancer—at least when it comes to certain genes. The new study reports that men who have the mutated breast cancer gene BRCA1 are nearly four times more likely to develop prostate cancer than men without the gene.  The BRCA1 (breast cancer 1, early onset) gene is a tumor suppressor gene, and it produces a protein that helps prevent cells from growing and dividing uncontrollably, as occurs in cancer. BRCA1 genes also provide instructions for making a protein…
  • Protein Discovery Could Lead to New Cancer Treatment

    Editor
    23 Apr 2012 | 5:39 pm
    Scientists at Lund University are on a quest to resolve a classic “if/then”  situation involving a protein discovery that could lead to new cancer treatment. Basically, if they can block a protein called gamma-tubulin, then targeted cancer cells should die while healthy cells survive. One major problem with cancer treatment is that most chemotherapy drugs and radiation therapy not only have an effect on cancerous cells, but also damage healthy cells. This cell damage results in side effects and complications that can seriously impact a patient’s quality of life. The Swedish…
  • Longevity and Healthy Life Years, a European Study

    Editor
    23 Apr 2012 | 5:38 pm
    Longevity is how long you live, but how long can you expect to live without disability? The measure of the latter is known as healthy life years, and according to figures released at the European Joint Action on Healthy Life Years, Swedish men had the highest healthy life years of European men in 2010. As the numbers of older adults grow ever larger, there is an accompanying growing interest and concern for issues that impact an aging population. One of the most pressing concerns expressed by aging adults is being disabled or incapacitated so they are not able to enjoy a good quality of life…
  • To Boost Your Creative Juices, Try Meditation

    Editor
    23 Apr 2012 | 5:36 pm
    If you have been looking for a way to boost your creative juices, you might want to try meditation. Researchers at Leiden University have published a report in Frontiers in Cognition noting the benefits of certain types of meditation in promoting creativity. For many years, both conventional and integrative physicians have been touting the stress reduction and relaxation benefits of meditation, and scores of studies have supported these claims. Meditation has demonstrated health advantages in cancer patients, individuals with asthma, people experiencing emotional distress, and those…
Log in